Phosphorylation |
Y39 |
|
[152] |
S87 |
conformational change in membrane-bound α-syn
decreased affinity to lipid vesicles
reduced aggregation of α-syn
|
[153] |
S129 |
reduced binding of α-syn monomers and Fe3+-induced oligomers to lipid vesicles
fewer α-helical structures, decreased binding, and disruption of lipid vesicles
no difference in membrane binding to synaptosomes
in the A30P variant, α-syn membrane binding was increased, leading to disruption of membranes
in the A53T variant, binding to membranes was reduced
|
[154,155,156] |
Acetylation |
M1 |
|
[157] |
Nitration |
Y39 |
|
[158] |
Y125 |
|
Y133, Y136 |
|
Ubiquitination |
K6, K23, K43, K96 |
|
[159,160] |
Truncation |
1–100 |
|
[161] |
1–103 |
|
[162] |
1–115 |
|
[163] |
1–119 |
|
[162] |
1–120 |
|
[164] |
1–121 |
similar aggregation to full-length α-syn in the presence of phospholipid vesicles
decreased ability to distort phospholipid membranes
higher toxicity compared to full-length α-syn
|
[165] |
Glycosylation |
T72 |
reduction in fibril formation, aggregation, and toxicity of monomeric α-syn in vitro, while binding affinity to lipid vesicles was unaltered
|
[166] |
T75 |
reduction in fibril formation, aggregation, and toxicity of monomeric α-syn in vitro, while binding affinity to lipid vesicles was unaltered
|
T81 |
reduction in fibril formation, aggregation, and toxicity of monomeric α-syn in vitro, while binding affinity to lipid vesicles was unaltered
|
S87 |
reduction in fibril formation, aggregation, and toxicity of monomeric α-syn in vitro, while binding affinity to lipid vesicles was unaltered
|
T72, T75, and T81 |
|
Glycation |
Lysine |
|
[167] |